New Retina Radio by Eyetube Podcast Por Retina Today arte de portada

New Retina Radio by Eyetube

New Retina Radio by Eyetube

De: Retina Today
Escúchala gratis

Acerca de esta escucha

 New Retina Radio is a place to hear stories about retina that are told nowhere else.2024 Bryn Mawr Communications LLC Ciencia
Episodios
  • ARVO '25: Real-World Next-Gen Anti-VEGF Dosing and TKIs in the Pipeline

    ARVO '25: Real-World Next-Gen Anti-VEGF Dosing and TKIs in the Pipeline
    May 22 2025
    Next-generation anti-VEGF agents are designed for durability. But does that actually change the rate at which they’re administered? David Miller, MD, joins us to review a pair of ARVO 2025 presentations that examined his clinic’s real-world administration patterns for bevacizumab (Avastin, Genentech), faricimab (Vabysmo, Genentech/Roche), and high-dose aflibercept (Eylea HD, Regeneron). What were the differences—and did they really matter? Also, Robert Wang, MD, helped us understand the state of play in the TKI pipeline as he shared data from the phase 2b ODYSSEY study. What are the latest data on CLX-AX (Clearside Biomedcial)? And where does it stack up against the other TKIs in the pipeline? Stick with us to find out.
    Más Menos
    23 m
  • GLP-1s and Risk of Age-Related Ocular Disease

    GLP-1s and Risk of Age-Related Ocular Disease
    May 16 2025
    How do GLP-1 drugs influence age-related ocular diseases such as macular degeneration and glaucoma? Moderator Lediana Goduni, MD, is joined by Alexis Warren, MD, and Joshua Uhr, MD, to examine a retrospective study published in Ophthalmology using TriNetX data to compare 5-year ocular outcomes across medication cohorts. Do these data suggest a protective benefit for GLP-1s—and does it matter for clinical practice? Tune in for their take on what’s promising, what’s premature, and what’s next.
    Más Menos
    18 m
  • Fellow Eye RRD Risk per IRIS Registry

    Fellow Eye RRD Risk per IRIS Registry
    May 8 2025
    Questions abound about fellow eye rhegmatogenous retinal detachments (RRD). How often do fellow eye develop RRD after the first one is repaired? What concomitant conditions do fellow eyes with RRD have? What risk factors exist for fellow eye RRD? And which procedures are used to repair fellow eye RRD? Moderator Barton Blackorby, MD, and panelists Louis Cai, MD, and Hong-Uyen Hua, MD, dissect the latest data on these questions from the AAO IRIS Registry and then compare how these data align with their respective clinical experiences.
    Más Menos
    17 m
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones